Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

[New views on immunopathology of viral hepatitis B and C].

Kráslová I, Vítek L, Muchová L, Naoumov NV.

Cas Lek Cesk. 2003;142(10):590-4. Review. Czech.

PMID:
14635421
2.

Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications.

Tsai SL, Sheen IS, Chien RN, Chu CM, Huang HC, Chuang YL, Lee TH, Liao SK, Lin CL, Kuo GC, Liaw YF.

J Biomed Sci. 2003 Jan-Feb;10(1):120-35.

PMID:
12566993
3.

Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).

Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.

Clin Ter. 2006 Jul-Aug;157(4):377-86. Review. Retraction in: Clin Ter. 2008 May-Jun;159(3):207.

PMID:
17051976
4.
5.

T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity.

Ichiki Y, He XS, Shimoda S, Ishibashi H, Keeffe EB, Rossaro L, Gershwin ME.

Autoimmun Rev. 2005 Feb;4(2):82-95. Epub 2005 Jan 12. Review.

PMID:
15722254
6.

Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.

Zhang Z, Zhang JY, Wherry EJ, Jin B, Xu B, Zou ZS, Zhang SY, Li BS, Wang HF, Wu H, Lau GK, Fu YX, Wang FS.

Gastroenterology. 2008 Jun;134(7):1938-49, 1949.e1-3. doi: 10.1053/j.gastro.2008.03.037. Epub 2008 Mar 22.

PMID:
18455515
7.

T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.

Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Díaz PV.

Pediatrics. 2006 May;117(5):e878-86. Epub 2006 Apr 17.

PMID:
16618789
8.

Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.

Quiroga JA, Llorente S, Castillo I, Rodríguez-Iñigo E, López-Alcorocho JM, Pardo M, Carreño V.

J Med Virol. 2006 Sep;78(9):1190-7.

PMID:
16847959
9.

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy.

Knutson KL, Disis ML.

Cancer Immunol Immunother. 2005 Aug;54(8):721-8. Epub 2005 Jan 27. Review.

PMID:
16010587
10.

Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines.

Jacobson Brown PM, Neuman MG.

Clin Biochem. 2001 May;34(3):167-71. Review.

PMID:
11408013
11.
12.

[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].

Panther E, Spangenberg HC, Neumann-Haefelin C, Rösler K, Blum HE, von Weizsäcker F, Thimme R.

Z Gastroenterol. 2004 Jan;42(1):39-46. Review. German.

PMID:
14997402
13.
14.

Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.

Aberle JH, Formann E, Steindl-Munda P, Weseslindtner L, Gurguta C, Perstinger G, Grilnberger E, Laferl H, Dienes HP, Popow-Kraupp T, Ferenci P, Holzmann H.

J Clin Virol. 2006 May;36(1):24-31. Epub 2006 Feb 17.

PMID:
16483838
15.

The role of cytotoxic T cells and cytokines in the control of hepatitis B virus infection.

Guidotti LG.

Vaccine. 2002 Dec 19;20 Suppl 4:A80-2. Review.

PMID:
12477433
16.

[Hepatitis B virus (HBV) and the inflammatory/immune response. I. The natural environment of the antigen presentation and immunologic chaos induced by the virus].

Villarrubia VG, Alvarez-Mon M, Chirigos MA, Herrerías JM.

Rev Esp Enferm Dig. 1997 Dec;89(12):919-28. Review. Spanish.

PMID:
9494379
18.

Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance.

Ito H, Ando K, Ishikawa T, Nakayama T, Taniguchi M, Saito K, Imawari M, Moriwaki H, Yokochi T, Kakumu S, Seishima M.

Int Immunol. 2008 Jul;20(7):869-79. doi: 10.1093/intimm/dxn046. Epub 2008 May 16.

PMID:
18487227
19.

Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells.

Durante-Mangoni E, Wang R, Shaulov A, He Q, Nasser I, Afdhal N, Koziel MJ, Exley MA.

J Immunol. 2004 Aug 1;173(3):2159-66.

20.

Supplemental Content

Support Center